These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor. Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236 [TBL] [Abstract][Full Text] [Related]
43. CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling. Sun H; Lin DC; Cao Q; Guo X; Marijon H; Zhao Z; Gery S; Xu L; Yang H; Pang B; Lee VK; Lim HJ; Doan N; Said JW; Chu P; Mayakonda A; Thomas T; Forscher C; Baloglu E; Shacham S; Rajalingam R; Koeffler HP Cancer Res; 2016 May; 76(9):2687-97. PubMed ID: 26956669 [TBL] [Abstract][Full Text] [Related]
44. In Vitro Sensitivity Profiling of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library to Identify Agents for Future Therapeutic Studies. Singh A; Meier-Stephenson V; Jayanthan A; Narendran A Curr Cancer Drug Targets; 2017; 17(6):569-584. PubMed ID: 27875952 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells. Zhai X; Yang Y; Wan J; Zhu R; Wu Y Oncol Rep; 2013 Dec; 30(6):2983-91. PubMed ID: 24064966 [TBL] [Abstract][Full Text] [Related]
46. Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells. Wu W; Ma J; Shao N; Shi Y; Liu R; Li W; Lin Y; Wang S PLoS One; 2017; 12(1):e0169229. PubMed ID: 28046018 [TBL] [Abstract][Full Text] [Related]
47. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397 [TBL] [Abstract][Full Text] [Related]
48. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells. He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174 [TBL] [Abstract][Full Text] [Related]
49. MET inhibitor PHA-665752 suppresses the hepatocyte growth factor-induced cell proliferation and radioresistance in nasopharyngeal carcinoma cells. Liu T; Li Q; Sun Q; Zhang Y; Yang H; Wang R; Chen L; Wang W Biochem Biophys Res Commun; 2014 Jun; 449(1):49-54. PubMed ID: 24802404 [TBL] [Abstract][Full Text] [Related]
50. Combination Treatment of OSI-906 with Aurora B Inhibitor Reduces Cell Viability via Cyclin B1 Degradation-Induced Mitotic Slippage. Ikeda Y; Yasutake R; Yuki R; Saito Y; Nakayama Y Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071893 [TBL] [Abstract][Full Text] [Related]
51. Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor. Davaadelger B; Duan L; Perez RE; Gitelis S; Maki CG Oncotarget; 2016 May; 7(19):27511-26. PubMed ID: 27050276 [TBL] [Abstract][Full Text] [Related]
52. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Buck E; Eyzaguirre A; Rosenfeld-Franklin M; Thomson S; Mulvihill M; Barr S; Brown E; O'Connor M; Yao Y; Pachter J; Miglarese M; Epstein D; Iwata KK; Haley JD; Gibson NW; Ji QS Cancer Res; 2008 Oct; 68(20):8322-32. PubMed ID: 18922904 [TBL] [Abstract][Full Text] [Related]
53. IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin. O'Flanagan CH; O'Shea S; Lyons A; Fogarty FM; McCabe N; Kennedy RD; O'Connor R Oncotarget; 2016 Aug; 7(35):56826-56841. PubMed ID: 27472395 [TBL] [Abstract][Full Text] [Related]
54. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress. Li Q; Ni W; Deng Z; Liu M; She L; Xie Q Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787 [TBL] [Abstract][Full Text] [Related]
55. A novel small molecule inhibitor of FAK and IGF-1R protein interactions decreases growth of human esophageal carcinoma. Ucar DA; Cox A; He DH; Ostrov DA; Kurenova E; Hochwald SN Anticancer Agents Med Chem; 2011 Sep; 11(7):629-37. PubMed ID: 21707510 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit. Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701 [TBL] [Abstract][Full Text] [Related]
57. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma. Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer. Yoshihiro T; Ariyama H; Yamaguchi K; Imajima T; Yamaga S; Tsuchihashi K; Isobe T; Kusaba H; Akashi K; Baba E Cancer Sci; 2022 Dec; 113(12):4207-4218. PubMed ID: 36053154 [TBL] [Abstract][Full Text] [Related]
59. Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells. Xu L; Qu X; Hu X; Zhu Z; Li C; Li E; Ma Y; Song N; Liu Y FEBS Lett; 2013 Nov; 587(23):3815-23. PubMed ID: 24161672 [TBL] [Abstract][Full Text] [Related]
60. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]